| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |